Amneal appoints Deborah M. Autor to Board of Directors, effective July 29, 2022

Amneal Pharmaceuticals, Inc.

Deborah M. Autor appointed independent director; will serve on Conflicts Committee.
Autor previously FDA Deputy Commissioner and Global Head at AstraZeneca and Mylan.
Board now comprises 11 directors following her appointment.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Deborah M. Autor

Director

AMRX · Amneal Pharmaceuticals, Inc.

Effective: 2022-07-29
Filed: August 3, 2022, 7:59 PM ET

On July 29, 2022, the Board of Directors (the “ Board ”) of Amneal Pharmaceuticals, Inc. (the “ Company ”) appointed Deborah M. Autor to the Company’s Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Deborah M. Autor was appointed as Director at Amneal Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 29, 2022, the Board of Directors (the “ Board ”) of Amneal Pharmaceuticals, Inc. (the “ Company ”) appointed Deborah M. Autor to the Company’s Board.

View on SEC.gov

Amneal Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-210639

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.